Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials

Mucinous ovarian carcinoma is a rare subtype of epithelial ovarian cancer. Despite being a chemoresistant tumour type, surgical resection and chemotherapy are still the current standard for management. This narrative review aims to explore the current evidence for targeted therapies in mucinous ovar...

Descripción completa

Detalles Bibliográficos
Autores principales: Nugawela, Devindee, Gorringe, Kylie L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811085/
https://www.ncbi.nlm.nih.gov/pubmed/36603894
http://dx.doi.org/10.1136/ijgc-2022-003658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811085/
https://www.ncbi.nlm.nih.gov/pubmed/36603894
http://dx.doi.org/10.1136/ijgc-2022-003658

Ejemplares similares